1. 97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird's Eye View. (4th December 2021) Authors: Tricou, Vianney; Biswal, Shibadas; Liu, Mengya; Patel, Sanjay S; Zent, Olaf; Rauscher, Martina; Perez, Gonzalo; Kandeil, Walid; Folschweiller, Nicolas Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country. Issue 7 (10th February 2023) Authors: Tricou, Vianney; Eyre, Susannah; Ramjee, Mahadev; Collini, Paul; Mojares, Zenaida; Loeliger, Edde; Mandaric, Sanja; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Folschweiller, Nicolas; Wallace, Derek Journal: Vaccine Issue: Volume 41:Issue 7(2023) Page Start: 1398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Issue 7 (3rd August 2019) Authors: Schwarz, Tino F.; Huang, Li-Min; Valencia, Alejandra; Panzer, Falko; Chiu, Cheng-Hsun; Decreux, Annabelle; Poncelet, Sylviane; Karkada, Naveen; Folschweiller, Nicolas; Lin, Lan; Dubin, Gary; Struyf, Frank Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 7/8(2019) Page Start: 1970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial. Issue 1 (2nd January 2018) Authors: Leung, Ting Fan; Liu, Anthony Pak-Yin; Lim, Fong Seng; Thollot, Franck; Oh, Helen May Lin; Lee, Bee Wah; Rombo, Lars; Tan, Ngiap Chuan; Rouzier, Roman; De Simoni, Stéphanie; Suryakiran, Pemmaraju; Hezareh, Marjan; Thomas, Florence; Folschweiller, Nicolas; Struyf, Frank Journal: Vaccine Issue: Volume 36:Issue 1(2018) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study. (5th September 2020) Authors: Tota, Joseph E; Struyf, Frank; Hildesheim, Allan; Gonzalez, Paula; Ryser, Martin; Herrero, Rolando; Schussler, John; Karkada, Naveen; Rodriguez, Ana Cecilia; Folschweiller, Nicolas; Porras, Carolina; Schiffman, Mark; Schiller, John T; Quint, Wim; Kreimer, Aimée R; Lehtinen, Matti; Wheeler, Cosett... Journal: Journal of infectious diseases Issue: Volume 223:Number 9(2021) Page Start: 1576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials. (7th November 2019) Authors: Tota, Joseph E; Struyf, Frank; Sampson, Joshua N; Gonzalez, Paula; Ryser, Martin; Herrero, Rolando; Schussler, John; Karkada, Naveen; Rodriguez, Ana Cecilia; Folschweiller, Nicolas; Porras, Carolina; Schiffman, Mark; Schiller, John T; Quint, Wim; Kreimer, Aimée R; Wheeler, Cosette M; Hildesheim, ... Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 8(2020) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study. (June 2020) Authors: Folschweiller, Nicolas; Teixeira, Julio; Joshi, Smita; Goldani, Luciano Z; Supparatpinyo, Khuanchai; Basu, Partha; Chotpitayasunondh, Tawee; Chetchotisakd, Ploenchan; Ruxrungtham, Kiat; Roteli-Martins, Cecilia; Grinsztejn, Beatriz; Quintana, Silvana Maria; Kumarasamy, Nagalingeswaran; Poongulali,... Journal: EClinicalMedicine Issue: Volume 23(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. (3rd February 2019) Authors: Folschweiller, Nicolas; Behre, Ulrich; Dionne, Marc; Durando, Paolo; Esposito, Susanna; Ferguson, Linda; Ferguson, Murdo; Hillemanns, Peter; McNeil, Shelly A; Peters, Klaus; Ramjattan, Brian; Schwarz, Tino F; Supparatpinyo, Khuanchai; Suryakirian, Pemmaraju V; Janssens, Michel; Moris, Philippe; D... Journal: Journal of infectious diseases Issue: Volume 219:Number 11(2019) Page Start: 1799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study. Issue 6 (11th August 2020) Authors: Hu, Yuemei; Zhang, Xiang; He, Yilin; Ma, Zhilong; Xie, Yan; Lu, Xiangbin; Xu, Yabin; Zhang, Yanqiu; Jiang, Yunyu; Xiao, Hui; Struyf, Frank; Folschweiller, Nicolas; Jiang, Johny; Poncelet, Sylviane; Karkada, Naveen; Jastorff, Archana; Borys, Dorota Journal: Asia-Pacific journal of clinical oncology Issue: Volume 16:Issue 6(2020) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Issue 5 (4th May 2017) Authors: Van Damme, Pierre; Leroux-Roels, Geert; Suryakiran, P.; Folschweiller, Nicolas; Van Der Meeren, Olivier Journal: Human vaccines & immunotherapeutics Issue: Volume 13:Issue 5(2017) Page Start: 972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗